|Videos|March 22, 2022
PharmExec CEO Roundtable: Hybrid Interactions
In this segment, executives discuss the need to adjust to virtual and in-person, face-to-face interactions with both internal and external stakeholders.
Advertisement
Please read the
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Unsolicited Proposal to Acquire Metsera
2
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
3
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
4
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
5
